US EditionPublished • loading... • Updated
US participating in influenza vaccine meeting: WHO
The U.S. maintains collaboration with WHO's global network of over 150 labs to update influenza vaccine strains biannually despite its recent WHO departure.
- At a WHO press conference on Wednesday, the United States announced it will join a World Health Organization meeting at the end of the month to set influenza vaccine composition.
- Washington's January decision to exit the WHO followed criticism of its COVID-19 pandemic management, leaving future cooperation uncertain but flu collaboration notable.
- Maria Van Kerkhove noted that the surveillance network of more than 150 laboratories across 130 countries updates vaccine recommendations every six months and shipments of influenza virus samples have resumed after funding challenges.
- WHO's six-month vaccine update cycle relies on resumed shipments allowing laboratories submitting virus samples to contribute data for the end of the month meeting.
- WHO Director-General Tedros Adhanom Ghebreyesus said `As far as WHO's position is concerned, it's unethical to proceed with this study`, while African health officials said the U.S.-funded hepatitis B newborn study in Guinea-Bissau will undergo further ethical review.
Insights by Ground AI
6 Articles
6 Articles
US to participate in meeting on influenza vaccine composition, WHO official says
The United States will take part in a World Health Organization meeting at the end of the month to determine the composition of upcoming influenza vaccines, the agency's official said at a press conference on Wednesday.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left0Leaning Right2Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
